Erlich et al. [16] reported that the interaction of PrPC with HOP modulates proliferation in glioma cell lines, and data from our group showed that higher expression of both proteins is correlated with greater tumor proliferation and lower survival in patients with GBM [15]. Here, STIP1 is linked to glioblastoma.